World-renowned stem cell scientist Gordon Keller, PhD, is the recipient of the 2019 Ogawa-Yamanaka Stem Cell Prize awarded by the Gladstone Institutes for his work with pluripotent stem cells.
Dr. Keller is the Director of the McEwen Stem Cell Institute at the University Health Network, Senior Scientist at Princess Margaret Cancer Centre and Professor in the department of medical biophysics at the University of Toronto. He was recognized for his contributions to efficient lineage-specific differentiation of human pluripotent stem cells into a myriad of cell types, enabling disease modeling and regenerative medicine approaches for many human diseases.
The prize was established in 2015 by the late Hiro and Betty Ogawa. The Centre for Commercialization of Regenerative Medicine (CCRM) nominated Dr. Keller who was selected by an independent committee of international stem cell experts. A ceremony will be held on November 6, 2019, at the Gladstone Institutes in San Francisco, California.